MyFinsight
Home
Blog
About
Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. (EDSA)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Accounts payable and accrued lia...
Share-based compensation
Depreciation and amortization
Negative Cash Flow Breakdown
Net loss
Payments for issuance costs of c...
Effect of exchange rate changes ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents at beginning of period
-
-
10,792,172
1,037,320
Net loss
-5,407,611
-4,218,332
-2,247,669
-2,228,358
Depreciation and amortization
25,644
25,872
25,460
25,868
Share-based compensation
547,463
484,853
399,862
404,425
Gain on loan forgiveness
-
-
-
0
Accounts and other receivable
16,140
-211,345
-217,387
359,828
Prepaid expenses and other current assets
25,313
-36,124
155,922
-34,477
Accounts payable and accrued liabilities
1,793,284
1,443,516
-326,452
402,422
Net cash used in operating activities
-3,082,673
-2,016,622
-2,087,334
-1,720,994
Proceeds from issuance of common shares
3,499,991
0
3,497,825
220,501
Proceeds from issuance of series a-1 preferred shares and warrants
0
0
0
0
Proceeds from issuance of series b-1 preferred shares-Series B1Preferred Stock
0
0
-
0
Payments for issuance costs of common shares-Common Stock And Warrants
53,054
8,980
142,406
34,018
Payments for issuance costs of common shares-Preferred Stock
0
0
-
0
Payment for issuance costs of warrants
0
0
-
0
Repayment of debt
-
-
-
0
Net cash provided by financing activities
3,446,937
-8,980
3,355,419
186,483
Effect of exchange rate changes on cash and cash equivalents
-35,427
-22,463
-8,509
-35,007
Net change in cash and cash equivalents
328,837
-2,048,065
1,259,576
-1,569,518
Cash and cash equivalents, beginning of the period
10,003,683
10,792,172
-
-
Cash and cash equivalents at end of period
-
-
12,051,748
10,792,172
Cash and cash equivalents, end of the period
10,332,520
10,003,683
-
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common shares
$3,499,991
(-53.32%↓ Y/Y)
Net cash provided by
financing activities
$3,446,937
(-79.54%↓ Y/Y)
Canceled cashflow
$53,054
Net change in cash
and cash...
$328,837
(-97.10%↓ Y/Y)
Canceled cashflow
$3,118,100
Payments for issuance
costs of common...
$53,054
(-82.01%↓ Y/Y)
Accounts payable and
accrued liabilities
$1,793,284
(260.41%↑ Y/Y)
Share-based compensation
$547,463
(68.34%↑ Y/Y)
Depreciation and
amortization
$25,644
(-72.55%↓ Y/Y)
Net cash used in
operating activities
-$3,082,673
(44.96%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$35,427
(-143.62%↓ Y/Y)
Canceled cashflow
$2,366,391
Net loss
-$5,407,611
(-9.09%↓ Y/Y)
Prepaid expenses and
other current assets
$25,313
(134.51%↑ Y/Y)
Accounts and other
receivable
$16,140
(-11.12%↓ Y/Y)
Buy us a coffee